{"address1": "Hulsterweg 82", "city": "Venlo", "zip": "5912 PL", "country": "Netherlands", "phone": "31 77 355 6600", "website": "https://www.qiagen.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, such as assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables, such as short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments; bioinformatics solutions; and custom laboratory and genomic services. The company provides software-as-a-service. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.", "fullTimeEmployees": 5067, "companyOfficers": [{"maxAge": 1, "name": "Mr. Thierry  Bernard", "age": 60, "title": "CEO, MD & Member of Management Board", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 2337567, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Roland  Sackers", "age": 56, "title": "CFO, MD & Member of Management Board", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 1212320, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Antonio  Santos", "title": "Senior VP & Head of Global Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Gilardi", "title": "Vice President of Corporate Communications & Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Dominic  John", "title": "Vice President of Marketing & Product Management", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stephany  Foster", "age": 45, "title": "Senior VP & Head of Human Resources", "yearBorn": 1979, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Thomas  Schweins", "title": "Senior Vice President of Life Science Business Area", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Thomas  Theuringer", "title": "Senior Director & Head of External Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jean-Pascal  Viola", "title": "Senior VP & Head of Corporate Strategy and Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jonathan G. Sheldon Ph.D.", "age": 52, "title": "Senior VP & Head of the QIAGEN Digital Insights Business Area", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 2, "compensationRisk": 2, "shareHolderRightsRisk": 6, "overallRisk": 2, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.qiagen.com/About-Us/Investors/", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 40.15, "open": 40.18, "dayLow": 39.375, "dayHigh": 40.2, "regularMarketPreviousClose": 40.15, "regularMarketOpen": 40.18, "regularMarketDayLow": 39.375, "regularMarketDayHigh": 40.2, "exDividendDate": 1738108800, "payoutRatio": 0.0, "beta": 0.443, "trailingPE": 103.94737, "forwardPE": 17.248909, "volume": 1586938, "regularMarketVolume": 1586938, "averageVolume": 1219883, "averageVolume10days": 973520, "averageDailyVolume10Day": 973520, "bid": 39.51, "ask": 39.55, "bidSize": 9, "askSize": 8, "marketCap": 8536582144, "fiftyTwoWeekLow": 37.63, "fiftyTwoWeekHigh": 47.93, "priceToSalesTrailing12Months": 4.3152976, "fiftyDayAverage": 40.8694, "twoHundredDayAverage": 43.1382, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 8896135168, "profitMargins": 0.04226, "floatShares": 214145123, "sharesOutstanding": 216116000, "sharesShort": 3716849, "sharesShortPriorMonth": 3158567, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0172, "heldPercentInsiders": 0.02279, "heldPercentInstitutions": 0.62143004, "shortRatio": 3.13, "shortPercentOfFloat": 0.0225, "impliedSharesOutstanding": 216115008, "bookValue": 16.507, "priceToBook": 2.3929243, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "earningsQuarterlyGrowth": -0.096, "netIncomeToCommon": 83591000, "trailingEps": 0.38, "forwardEps": 2.29, "lastSplitFactor": "962:1000", "lastSplitDate": 1485302400, "enterpriseToRevenue": 4.497, "enterpriseToEbitda": 12.983, "52WeekChange": -0.057504177, "SandP52WeekChange": 0.08089435, "lastDividendValue": 1.32, "lastDividendDate": 1706572800, "quoteType": "EQUITY", "currentPrice": 39.5, "targetHighPrice": 55.0, "targetLowPrice": 42.0, "targetMeanPrice": 49.79705, "targetMedianPrice": 49.5, "recommendationMean": 2.11111, "recommendationKey": "buy", "numberOfAnalystOpinions": 16, "totalCash": 1152992000, "totalCashPerShare": 5.335, "ebitda": 685225024, "totalDebt": 1512541056, "quickRatio": 2.933, "currentRatio": 3.605, "totalRevenue": 1978214016, "debtToEquity": 42.4, "revenuePerShare": 9.14, "returnOnAssets": 0.052410003, "returnOnEquity": 0.022669999, "grossProfits": 1320948992, "freeCashflow": 655703488, "operatingCashflow": 673550976, "earningsGrowth": -0.098, "revenueGrowth": 0.024, "grossMargins": 0.66775, "ebitdaMargins": 0.34639, "operatingMargins": 0.27719998, "financialCurrency": "USD", "symbol": "QGEN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 835968600000, "preMarketChange": -0.08000183, "preMarketChangePercent": -0.20253628, "preMarketPrice": 39.42, "marketState": "PRE", "regularMarketChangePercent": -1.61893, "regularMarketPrice": 39.5, "shortName": "Qiagen N.V.", "longName": "Qiagen N.V.", "regularMarketChange": -0.650002, "regularMarketDayRange": "39.375 - 40.2", "fullExchangeName": "NYSE", "averageDailyVolume3Month": 1219883, "fiftyTwoWeekLowChange": 1.8699989, "fiftyTwoWeekLowChangePercent": 0.049694363, "fiftyTwoWeekRange": "37.63 - 47.93", "fiftyTwoWeekHighChange": -8.43, "fiftyTwoWeekHighChangePercent": -0.1758815, "fiftyTwoWeekChangePercent": -5.7504177, "dividendDate": 1738108800, "earningsTimestamp": 1738789200, "earningsTimestampStart": 1746043500, "earningsTimestampEnd": 1746389100, "earningsCallTimestampStart": 1738854000, "earningsCallTimestampEnd": 1738854000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 0.38, "epsForward": 2.29, "epsCurrentYear": 2.28709, "priceEpsCurrentYear": 17.270855, "fiftyDayAverageChange": -1.3694, "fiftyDayAverageChangePercent": -0.033506732, "twoHundredDayAverageChange": -3.6381989, "twoHundredDayAverageChangePercent": -0.08433822, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.1 - Buy", "corporateActions": [], "preMarketTime": 1743599393, "regularMarketTime": 1743537652, "exchange": "NYQ", "messageBoardId": "finmb_33471", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Qiagen", "trailingPegRatio": 0.9109}